Interleukin‐39 is a Prognostic Biomarker and Therapy Target for Sepsis

Feng‐zhi Zhang, Hai‐jun Liu, Yan Yue, Jun‐jie Gao, Jin Zhang, Wen‐wu Zhang, Yun‐long Zhang, Wei‐hua Lu, Sheng‐wei Jin, Pu‐hong Zhang

Open source

DOI
10.1002/advs.77663
Published
2026-09-10
Container
Advanced Science
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/advs.77663,
  title = {Interleukin‐39 is a Prognostic Biomarker and Therapy Target for Sepsis},
  author = {Feng‐zhi Zhang and Hai‐jun Liu and Yan Yue and Jun‐jie Gao and Jin Zhang and Wen‐wu Zhang and Yun‐long Zhang and Wei‐hua Lu and Sheng‐wei Jin and Pu‐hong Zhang},
  year = {2026},
  journal = {Advanced Science},
  doi = {10.1002/advs.77663},
  url = {https://doi.org/10.1002/advs.77663}
}

RIS

TY  - JOUR
TI  - Interleukin‐39 is a Prognostic Biomarker and Therapy Target for Sepsis
AU  - Feng‐zhi Zhang
AU  - Hai‐jun Liu
AU  - Yan Yue
AU  - Jun‐jie Gao
AU  - Jin Zhang
AU  - Wen‐wu Zhang
AU  - Yun‐long Zhang
AU  - Wei‐hua Lu
AU  - Sheng‐wei Jin
AU  - Pu‐hong Zhang
PY  - 2026
JO  - Advanced Science
DO  - 10.1002/advs.77663
UR  - https://doi.org/10.1002/advs.77663
ER  - 

APA

Zhang, F., Liu, H., Yue, Y., Gao, J., Zhang, J., Zhang, W., Zhang, Y., Lu, W., Jin, S., & Zhang, P. (2026). Interleukin‐39 is a Prognostic Biomarker and Therapy Target for Sepsis. Advanced Science. https://doi.org/10.1002/advs.77663

Source records